X

Quality Statement

Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety.

X

Image Use Agreement

By downloading, copying, or making any use of the images located on this website (“Site”) you acknowledge that you have read and understand, and agree to, the terms of this Image Usage Agreement, as well as the terms provided on the Legal Notices webpage, which together govern your use of the images as provided below. If you do not agree to such terms, do not download, copy or use the images in any way, unless you have written permission signed by an authorized Pacific Biosciences representative.

Subject to the terms of this Agreement and the terms provided on the Legal Notices webpage (to the extent they do not conflict with the terms of this Agreement), you may use the images on the Site solely for (a) editorial use by press and/or industry analysts, (b) in connection with a normal, peer-reviewed, scientific publication, book or presentation, or the like. You may not alter or modify any image, in whole or in part, for any reason. You may not use any image in a manner that misrepresents the associated Pacific Biosciences product, service or technology or any associated characteristics, data, or properties thereof. You also may not use any image in a manner that denotes some representation or warranty (express, implied or statutory) from Pacific Biosciences of the product, service or technology. The rights granted by this Agreement are personal to you and are not transferable by you to another party.

You, and not Pacific Biosciences, are responsible for your use of the images. You acknowledge and agree that any misuse of the images or breach of this Agreement will cause Pacific Biosciences irreparable harm. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. You must include any copyright notice originally included with the images on all copies.

IMAGES ARE PROVIDED BY Pacific Biosciences ON AN "AS-IS" BASIS. Pacific Biosciences DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO, NON-INFRINGEMENT, OWNERSHIP, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL Pacific Biosciences BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER WITH RESPECT TO THE IMAGES.

You agree that Pacific Biosciences may terminate your access to and use of the images located on the PacificBiosciences.com website at any time and without prior notice, if it considers you to have violated any of the terms of this Image Use Agreement. You agree to indemnify, defend and hold harmless Pacific Biosciences, its officers, directors, employees, agents, licensors, suppliers and any third party information providers to the Site from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of the terms of this Image Use Agreement or Pacific Biosciences' termination of your access to or use of the Site. Termination will not affect Pacific Biosciences' rights or your obligations which accrued before the termination.

I have read and understand, and agree to, the Image Usage Agreement.

I disagree and would like to return to the Pacific Biosciences home page.

Pacific Biosciences
Contact:

Pacific Biosciences Names Michael W. Hunkapiller Chief Executive Officer

Friday, January 6, 2012

MENLO PARK, Calif.–(BUSINESS WIRE)–

Pacific Biosciences of California, Inc. (NASDAQ:PACB), provider of

Single Molecule Real Time (SMRT®) sequencing products, today

announced the appointment of Michael W. Hunkapiller, Ph.D., as President

and Chief Executive Officer effective immediately. He succeeds Hugh

Martin, who will remain on the Board of Directors through the company’s

next annual meeting of shareholders.

Dr. Hunkapiller was named Executive Chairman of PacBio’s Board of

Directors in October 2011. Dr. Hunkapiller spent 21 years of his career

helping build Applied Biosystems (“ABI,” now part of Life Technologies

Inc.) into a market leader in the life sciences industry. From 1995 to

2004 he served as ABI’s President and General Manager. In 2004 he joined

Alloy Ventures as a General Partner, and in 2005 led Alloy’s investment

in PacBio and joined the company’s Board of Directors. Dr. Hunkapiller

will continue to represent Alloy Ventures as a Director of NuGEN,

Verinata Health and RainDance Technologies.

“I am excited and honored to take on the role of President and CEO of

PacBio,” said Dr. Hunkapiller. “Since joining the company’s Board, I

have always believed that our SMRT technology would play a significant

role in biological research and the advancement of medical therapies.

Now that we have begun to deliver products to customers, I am more

convinced than ever that we are on our way to fulfilling that promise.

The company is in great position with the people, products, and cash to

drive the adoption of its disruptive technology.”

Bill Ericson, PacBio’s lead independent Board Member and Mohr Davidow

General Partner commented: “We are thankful for Hugh’s dedication and

efforts in transforming PacBio from an early stage R&D company to a

leader in single molecule technology. Mike brings unmatched expertise,

experience and relationships with customers in the life science tools

market and is uniquely qualified to lead the company through its next

stage of growth.”

Mr. Martin commented: “Developing a technology as advanced as single

molecule sequencing was a tremendous achievement for PacBio, and Mike is

now the ideal person to drive the broader adoption of PacBio’s products.

I am in support of this decision and am looking forward to identifying

my next exciting career venture.”

For more information about Pacific Biosciences, please visit www.pacificbiosciences.com.

You can also follow the company on Twitter www.twitter.com/pacbio.

About Pacific Biosciences

Pacific Biosciences’ mission is to transform the way humankind acquires,

processes and interprets data from living systems through the design,

development and commercialization of innovative tools for biological

research. The company has developed a novel approach to studying the

synthesis and regulation of DNA, RNA and proteins. Combining recent

advances in nanofabrication, biochemistry, molecular biology, surface

chemistry and optics, Pacific Biosciences has created a powerful

technology platform called single molecule, real-time, or SMRT®,

technology. SMRT technology enables real-time analysis of biomolecules

with single molecule resolution, which has the potential to transform

the understanding of biological systems by providing a window into these

systems that has not previously been open for scientific study.

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking

statements may contain words such as “believe,” “may,” “estimate,”

“anticipate,” “continue,” “intend,” “expect,” “plan,” the negative of

these terms, or other similar expressions, and include the assumptions

that underlie such statements. Such statements include, but are not

limited to, statements regarding the Company’s SMRT technology and the

Company’s growth. These statements are subject to known and unknown

risks and uncertainties that could cause actual results to differ

materially from those expressed or implied by such statements, including

but not limited to risks discussed from time to time in documents

Pacific Biosciences of California, Inc. has filed with the Securities

and Exchange Commission, including the risks identified under the

section captioned “Risk Factors” in its recently filed Quarterly Report

on Form 10-Q. All forward-looking statements are based on estimates,

projections and assumptions as of the date hereof. Pacific Biosciences

undertakes no obligation to update any forward-looking statements.

For Pacific BiosciencesNicole Litchfield, 415-793-6468 (Media)
nicole@bioscribe.com
or
Pacific

BiosciencesTrevin Rard, 650-521-8450 (Investors)
ir@pacificbiosciences.com

Source: Pacific Biosciences of California, Inc.

News Provided by Acquire Media

Press Release

Pacific Biosciences Announces New Chief Financial Officer

Monday, September 14, 2020

Stay
Current

Visit our blog »